{"url_path":"/sec/mbot/8-k/2026-08-11/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-037031-index.html","accession_number":"0001493152-26-037031","cik":"0000883975","ticker":"MBOT","issuer_name":"Microbot Medical Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/883975/0001493152-26-037031-index.html","primary_entity_key":"0000883975","primary_entity_name":"Microbot Medical Inc."},"word_count":180,"has_tables":true,"body_markdown":"** **\n\n**Item\n7.01 Regulation FD Disclosure.**\n\n \n\nOn\nAugust 11, 2026, Microbot Medical Inc. (the “Company”) disseminated a press release announcing that it has filed its Quarterly\nReport on Form 10-Q for the fiscal quarter ended June 30, 2026, and providing highlights of the Company’s second quarter ended\nJune 30, 2026. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.\n\n \n\nThe\ninformation in this Item 7.01, including the attached exhibit, is being furnished, and shall not be deemed to be filed for purposes of\nSection 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities\nof that section, nor shall it be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Exchange\nAct, regardless of any incorporation by reference language of such filing. By furnishing the information in this Current Report on Form\n8-K (“Form 8-K”) and the attached exhibit, the Company is making no admission as to the materiality of any information in\nthis Form 8-K or the exhibit."}